| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |